pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 16·1 min read
save

Defense Secretary proposes annual testosterone screening for service members, sparking mixed expert reaction

Jul 16, 2026·read at STAT ↗Neutral

U.S. Defense Secretary Pete Hegseth announced that service members will have testosterone deficiency testing added to their annual physical exams. The plan targets war-fighters aged 30 and older, with optional testing offered to younger personnel who may request it.

Hegseth said the screenings will be part of the periodic health assessment and that any resulting testosterone replacement therapy would be decided by the individual under medical guidance.

Medical experts reacted sharply divided. Some praised the initiative as a valuable step toward identifying a treatable condition in a high-risk population, while others labeled the policy as unnecessary or "crazy," warning that widespread testing could lead to over-diagnosis.

The announcement also highlights the expanding market for testosterone replacement therapy, a product that has grown in recent years despite limited evidence for use beyond clinically confirmed deficiency.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “Pete Hegseth’s announcement of annual testosterone screenings for service members divides medical experts”

read at STAT ↗
1,209 words · retrieved Jul 16
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
UNIQUE2Johns Hopkins UniversityLEADINGUltragenyx Pharmaceutical Inc.
drugs
Bio T32Testim32Vogelxo32testosterone32
topics
Oncology2Psychiatry & CNS2HematologyHepatologyNephrologyProstate CancerRare DiseaseUrologyVaccine

related stories

  • Dec 22Fierce Biotech Fundraising Tracker '26: Superluminal snags $60M; AusperBio adds $120MFierce Biotech
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • Jun 4Male puberty is understudied — but when it starts may predict long-term health risksSTAT
  • 19m agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Aug 5MRI is standard for diagnosing prostate cancer in most western countries. But most U.S. men don’t get themSTAT